This is a prospective cohort study to examine the efficacy of ESMR application in patients with refractory angina despite optimal medical therapy, not suitable for further PCI or CABG. Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and hospitalization were compared at baseline and 1, 6 and 12 months after ESMR therapy. The effect on cardiac perfusion was assessed at 6 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
122
extracorporeal shockwave in ischemic area evaluated by SPECT
Improvement of myocardial perfusion
Reduction in stress-induced ischemia at SPECT
Time frame: 6months after ESMR
Reduction of symptoms
Improvement of CCS class
Time frame: 1, 6, 12 months
Reduction of symptoms
Improvement of NYHA class
Time frame: 1, 6, 12 months
Reduction of symptoms
Reduction of oral nitrates need
Time frame: 1, 6, 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.